Singapore Medical Group's potential share transaction with third party to be dropped
SINGAPORE Medical Group (SMG) announced that a potential transaction involving its company's shares will not be explored further, according to an exchange filing on Thursday.
In December last year, the group said that it was in preliminary discussions with a third party regarding a transaction involving SMG's shares. This was shared in response to a query from its sponsor CIMB Bank Singapore regarding "unusual price movements" and the significant volume of trading in the shares.
In the filing, SMG said that it remains open to exploring various avenues to improve shareholder value, including corporate actions.
As at 9.35am on Thursday, SMG shares were trading at 31 Singapore cents, down 3.5 cents or 10.1 per cent.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance